About
Technology
Issues
FAQ
Links
Official Page
Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.